Agenus
AGEN
#9073
Rank
C$0.17 B
Marketcap
C$4.64
Share price
3.09%
Change (1 day)
115.15%
Change (1 year)

Earnings for Agenus (AGEN)

Earnings in 2025 (TTM): C$27.55 Million

According to Agenus 's latest financial reports the company's current earnings are C$0.10 Billion. In 2024 the company made an earning of -C$0.16 Billion, an increase over its 2023 earnings that were of -C$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agenus from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$27.55 M-117.29%
2024 -C$0.16 Billion-28.13%
2023 -C$0.23 Billion-5.5%
2022 -C$0.24 Billion-556.26%
2021 C$51.43 M-130.37%
2020 -C$0.17 Billion73.75%
2019 -C$97.47 Million-48.74%
2018 -C$0.2 Billion34.32%
2017 -C$0.15 Billion-7.16%
2016 -C$0.16 Billion26.55%
2015 -C$0.13 Billion110.24%
2014 -C$57.32 Million49.12%
2013 -C$38.44 Million
2011 -C$26.54 Million-12.25%
2010 -C$30.25 Million-21.41%
2009 -C$38.48 Million-26.86%
2008 -C$52.62 Million13.72%
2007 -C$46.27 Million-33.4%
2006 -C$69.47 Million-31.84%
2005 -C$0.11 Billion9.74%
2004 -C$92.87 Million-0.8%
2003 -C$93.62 Million17.37%
2002 -C$79.77 Million37.83%
2001 -C$57.87 Million55.99%
2000 -C$37.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$46.64 B 162,277.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$31.17 B 108,417.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$12.96 B 45,043.49%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$13.75 B 47,791.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-C$0.4 Billion-1,490.73%๐Ÿ‡บ๐Ÿ‡ธ USA